Title: Bile acid alterations in non-alcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?

Abstract : Disclosure: The authors declare no conflict of interest. 2 Abstract Purpose of review: To discuss the influence of obesity, insulin resistance, type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD) on bile acid (BA) metabolism and analyze whether these findings reinforce current beliefs about the role of BAs in the pathophysiology of these diseases. Recent findings: Discordant results on plasma BA alterations in NAFLD patients have been reported. Obesity, insulin resistance and T2D, common co-morbidities of NAFLD, have been associated with BA changes, but the individual BA species variations differ between studies (summarized in this review), perhaps due to clinico-biological differences between the studied patient populations and the heterogeneity of statistical analyses applied. Summary: The regulatory role of BAs in metabolic and cellular homeostasis render BAs attractive candidates as players in the pathophysiology of NAFLD. However, considering the complex
Document type :
Journal articles
Complete list of metadatas

Cited literature [3 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02302134
Contributor : Marie-Hélène Derudas <>
Submitted on : Tuesday, October 1, 2019 - 10:31:39 AM
Last modification on : Wednesday, October 2, 2019 - 1:11:23 AM

Identifiers

Collections

Citation

Oscar Chávez-Talavera, Joël Haas, Guillaume Grzych, Anne Tailleux, Bart Staels. Title: Bile acid alterations in non-alcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?. Current Opinion in Lipidology, Lippincott, Williams & Wilkins, 2019, 30 (3), pp.244-254. ⟨10.1097/MOL.0000000000000597⟩. ⟨inserm-02302134⟩

Share

Metrics

Record views

41

Files downloads

3